Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Name: Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
License: Public Domain

Mayo Clinic

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced fallopian tube carcinoma, advanced fallopian tube high grade serous adenocarcinoma, advanced ovarian carcinoma, advanced ovarian carcinosarcoma, advanced ovarian clear cell adenocarcinoma, advanced ovarian endometrioid adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 467610
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.